HIGHLIGHTS
- who: Akram Al-Ibraheem and collaborators from the Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center, Al-Jubeiha, Department of Radiology and Nuclear Medicine, Division of Nuclear Medicine, University of have published the research work: FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects, in the Journal: Cancers 2023, 15, x FOR PEER REVIEW of /2023/
- what: The aim of this review is to address the efficacy and side effects of cancer and to correlate this with the proposed criteria and relevant patterns of FDG PET . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.